246 related articles for article (PubMed ID: 26259750)
1. Never in mitosis gene A-related kinase 6 and aurora kinase A: New gene biomarkers in the conversion from ulcerative colitis to colorectal cancer.
Gerçeker E; Boyacıoglu SO; Kasap E; Baykan A; Yuceyar H; Yıldırım H; Ayhan S; Ellidokuz E; Korkmaz M
Oncol Rep; 2015 Oct; 34(4):1905-14. PubMed ID: 26259750
[TBL] [Abstract][Full Text] [Related]
2. The potential role of the NEK6, AURKA, AURKB, and PAK1 genes in adenomatous colorectal polyps and colorectal adenocarcinoma.
Kasap E; Gerceker E; Boyacıoglu SÖ; Yuceyar H; Yıldırm H; Ayhan S; Korkmaz M
Tumour Biol; 2016 Mar; 37(3):3071-80. PubMed ID: 26423403
[TBL] [Abstract][Full Text] [Related]
3. Expression profiles of histone modification genes in gastric cancer progression.
Orenay-Boyacioglu S; Kasap E; Gerceker E; Yuceyar H; Demirci U; Bilgic F; Korkmaz M
Mol Biol Rep; 2018 Dec; 45(6):2275-2282. PubMed ID: 30250993
[TBL] [Abstract][Full Text] [Related]
4. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
5. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
6. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
Wu D; Li Q; Song G; Lu J
J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
[TBL] [Abstract][Full Text] [Related]
7. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
[TBL] [Abstract][Full Text] [Related]
8. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy.
Shivakumar BM; Kumar BL; Bhat G; Suvarna D; Rao L; Pai CG; Satyamoorthy K
J Crohns Colitis; 2012 Jul; 6(6):647-54. PubMed ID: 22398042
[TBL] [Abstract][Full Text] [Related]
9. Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
Kisiel JB; Garrity-Park MM; Taylor WR; Smyrk TC; Ahlquist DA
Inflamm Bowel Dis; 2013 Sep; 19(10):2079-83. PubMed ID: 23867875
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
11. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
[TBL] [Abstract][Full Text] [Related]
13. Associations between markers of colorectal cancer stem cells, mutation, microRNA and the clinical features of ulcerative colitis.
Yang L; Levi E; Du JH; Zhou HH; Miller R; Majumdar AP
Colorectal Dis; 2016 Jun; 18(6):O185-93. PubMed ID: 27153478
[TBL] [Abstract][Full Text] [Related]
14. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the BRAF gene in ulcerative colitis-related colorectal carcinoma.
Aust DE; Haase M; Dobryden L; Markwarth A; Löhrs U; Wittekind C; Baretton GB; Tannapfel A
Int J Cancer; 2005 Jul; 115(5):673-7. PubMed ID: 15704157
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation.
Garrity-Park M; Loftus EV; Sandborn WJ; Smyrk TC
Inflamm Bowel Dis; 2012 Feb; 18(2):275-83. PubMed ID: 21425209
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis.
Kim TO; Park J; Kang MJ; Lee SH; Jee SR; Ryu DY; Yang K; Yi JM
Int J Mol Med; 2013 May; 31(5):1255-61. PubMed ID: 23546389
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
Brüwer M; Schmid KW; Senninger N; Schürmann G
World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Bryant SC; Sandborn WJ; Smyrk TC
Am J Gastroenterol; 2008 Feb; 103(2):407-15. PubMed ID: 18289203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
